JPRN-UMIN000048108Completed未知
Efficacy of Aflibercept for macular edema - Efficacy of Aflibercept for macular edema
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Chiba University
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have not been followed up for more than 1 year
Investigators
Similar Trials
Recruiting
Not Applicable
Efficacy of aflibercept for Macular edema secondary to central retinal vein occlusion (CRVO)central retinal vein occlusionJPRN-UMIN000014505Asahikawa Medical University30
Active, not recruiting
Phase 1
Prospective non-randomised pilot study looking at the safety and efficacy of a drug called Eylea for patients with an eye condition called Retinitis Pigmentosa, that also have swelling at the back of the eyeRetinitis Pigmentosa associated Cystoid Macular OedemaMedDRA version: 18.1 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2015-003723-65-GBMoorfields Eye Hospital30
Unknown
Not Applicable
Aflibercept treat and extend for macular edema secondary to branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000027100Jikei daisan hospital50
Active, not recruiting
Phase 1
Antibody treatment in retinal vein occulsion and the influence on oxygen and blood supplyretinal vein occlusionEUCTR2016-001660-10-ATniversitätsklinik für Augenheilkunde und Optometrie30
Completed
Not Applicable
Effect of aflibercept in wet age-related macular degenaration (wAMD) with retinal pigment epithelium detachment (PED)exudative age related macular degenerationJPRN-UMIN000011273Kansai Medical University50